Intercept wasn't the only biotech in line for a drubbing today. ... Biopharma, a tiny immuno-oncology startup based in San Antonio, filed for $25 million.
News
- Heron earns a second slapdown from the FDA on pain med — shares wither
- The biotech IPO boom is becoming 'historic' as four more throw their hats in
... a tiny immuno-oncology startup based in San Antonio, filed for $25 million. These companies will try to capitalize on a 2020 biotech IPO boom that ...
- Covid-19 roundup: Temasek leads a $250M raise for BioNTech as first Covid-19 mRNA vaccine ...
Temasek is leading a $250 million injection into the German biotech, one of a small pack of ... Intercept wasn't the only biotech in line for a drubbing today. ... a tiny immuno-oncology startup based in San Antonio, filed for $25 million.
- Coty, Boeing rise; Intercept Therapeutics, Heron fall
The Food and Drug Administration declined to approve the biotechnology company's liver disease drug. Coty Inc., up 56 cents to $4.74. The owner of ...
- Biopsy Devices Market to Eyewitness Massive Growth by 2026 | Boston University, Carlos III Health ...
... San Antonio, University of Twente, University of Washington, Vanderbilt University, Vascular BioSciences, Verisante Technology Inc, VitruMed Inc., ...